CGP12177-induced haemodynamic and vascular effects in normotensive and hypertensive rats

Delphine Holopherne, Mohamed Yassine Mallem, Erwan Le Strat, Eric Jacques Belin de Chantemele, Marc Gogny, Daniel Henrion, Jacques Noireaud, Jean Claude Desfontis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

CGP12177 is a non-conventional partial agonist, known to have cardiostimulating and vasorelaxant properties related to its agonist action on the low affinity state of the β1-adrenoceptor (β1LA-adrenoceptor). In normotensive Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SHR), CGP12177-induced vasorelaxant effects were analysed in hindquarter vessels to assess modifications in hind limb vascular resistance, and in femoral artery rings. The global haemodynamic effects induced by CGP12177 were also investigated using telemetry in conscious animals. In hindquarters vasculature precontracted with 5-hydroxytryptamine, CGP12177 (0.16 to 475 μg) produced a similar dose-dependent decrease in hindquarters perfusion pressure in both strains. Vasorelaxation was not modified by nadolol, a β1 and β2-adrenoreceptor antagonist, nor by L748337, a β3-adrenoceptor antagonist, but was concentration dependently inhibited by bupranolol, a β1LA-adrenoceptor antagonist at high concentrations. In femoral artery rings from WKY rats and SHR, CGP12177 produced a concentration-dependent relaxation, which was unaffected by nitric oxide synthases inhibition but was significantly reduced in the presence of bupranolol. With double cardiac autonomic blockade (atropine plus atenolol) in conscious WKY rats and SHR, CGP12177 greatly increased heart rate with minor changes in mean arterial pressure in both strains. Conversely, in the absence of double cardiac autonomic blockade, the amplitude of CGP12177-induced heart rate increase was less pronounced and had an hypotensive effect. The reduction in tachycardia and the hypotension were significantly greater in SHR compared to WKY rats. In conclusion, in both strains, CGP12177 produced vasodilating effects in hindquarter vessels and femoral arteries that can be attributed to a β1LA-adrenoceptor stimulation. In conscious WKY rats and SHR, CGP12177-induced cardiostimulation and hypotension were not significantly different after baroreflex blockade, but were decreased and increased respectively, in the presence of baroreflex activity.

Original languageEnglish (US)
Pages (from-to)196-202
Number of pages7
JournalEuropean Journal of Pharmacology
Volume591
Issue number1-3
DOIs
StatePublished - Sep 4 2008
Externally publishedYes

Fingerprint

Inbred WKY Rats
Inbred SHR Rats
Blood Vessels
Hemodynamics
Adrenergic Receptors
Bupranolol
Femoral Artery
Baroreflex
Vasodilator Agents
L 748,337
Heart Rate
Controlled Hypotension
Nadolol
Telemetry
Atenolol
Atropine
Tachycardia
Vasodilation
Nitric Oxide Synthase
Vascular Resistance

Keywords

  • CGP12177
  • Femoral artery
  • Haemodynamic effects
  • Hypertension
  • Isolated perfused hindquarters
  • Low affinity β-adrenoceptor
  • Telemetry

ASJC Scopus subject areas

  • Pharmacology

Cite this

CGP12177-induced haemodynamic and vascular effects in normotensive and hypertensive rats. / Holopherne, Delphine; Mallem, Mohamed Yassine; Le Strat, Erwan; Belin de Chantemele, Eric Jacques; Gogny, Marc; Henrion, Daniel; Noireaud, Jacques; Desfontis, Jean Claude.

In: European Journal of Pharmacology, Vol. 591, No. 1-3, 04.09.2008, p. 196-202.

Research output: Contribution to journalArticle

Holopherne, D, Mallem, MY, Le Strat, E, Belin de Chantemele, EJ, Gogny, M, Henrion, D, Noireaud, J & Desfontis, JC 2008, 'CGP12177-induced haemodynamic and vascular effects in normotensive and hypertensive rats', European Journal of Pharmacology, vol. 591, no. 1-3, pp. 196-202. https://doi.org/10.1016/j.ejphar.2008.06.060
Holopherne, Delphine ; Mallem, Mohamed Yassine ; Le Strat, Erwan ; Belin de Chantemele, Eric Jacques ; Gogny, Marc ; Henrion, Daniel ; Noireaud, Jacques ; Desfontis, Jean Claude. / CGP12177-induced haemodynamic and vascular effects in normotensive and hypertensive rats. In: European Journal of Pharmacology. 2008 ; Vol. 591, No. 1-3. pp. 196-202.
@article{e6768d8e326e47398709124c8900560f,
title = "CGP12177-induced haemodynamic and vascular effects in normotensive and hypertensive rats",
abstract = "CGP12177 is a non-conventional partial agonist, known to have cardiostimulating and vasorelaxant properties related to its agonist action on the low affinity state of the β1-adrenoceptor (β1LA-adrenoceptor). In normotensive Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SHR), CGP12177-induced vasorelaxant effects were analysed in hindquarter vessels to assess modifications in hind limb vascular resistance, and in femoral artery rings. The global haemodynamic effects induced by CGP12177 were also investigated using telemetry in conscious animals. In hindquarters vasculature precontracted with 5-hydroxytryptamine, CGP12177 (0.16 to 475 μg) produced a similar dose-dependent decrease in hindquarters perfusion pressure in both strains. Vasorelaxation was not modified by nadolol, a β1 and β2-adrenoreceptor antagonist, nor by L748337, a β3-adrenoceptor antagonist, but was concentration dependently inhibited by bupranolol, a β1LA-adrenoceptor antagonist at high concentrations. In femoral artery rings from WKY rats and SHR, CGP12177 produced a concentration-dependent relaxation, which was unaffected by nitric oxide synthases inhibition but was significantly reduced in the presence of bupranolol. With double cardiac autonomic blockade (atropine plus atenolol) in conscious WKY rats and SHR, CGP12177 greatly increased heart rate with minor changes in mean arterial pressure in both strains. Conversely, in the absence of double cardiac autonomic blockade, the amplitude of CGP12177-induced heart rate increase was less pronounced and had an hypotensive effect. The reduction in tachycardia and the hypotension were significantly greater in SHR compared to WKY rats. In conclusion, in both strains, CGP12177 produced vasodilating effects in hindquarter vessels and femoral arteries that can be attributed to a β1LA-adrenoceptor stimulation. In conscious WKY rats and SHR, CGP12177-induced cardiostimulation and hypotension were not significantly different after baroreflex blockade, but were decreased and increased respectively, in the presence of baroreflex activity.",
keywords = "CGP12177, Femoral artery, Haemodynamic effects, Hypertension, Isolated perfused hindquarters, Low affinity β-adrenoceptor, Telemetry",
author = "Delphine Holopherne and Mallem, {Mohamed Yassine} and {Le Strat}, Erwan and {Belin de Chantemele}, {Eric Jacques} and Marc Gogny and Daniel Henrion and Jacques Noireaud and Desfontis, {Jean Claude}",
year = "2008",
month = "9",
day = "4",
doi = "10.1016/j.ejphar.2008.06.060",
language = "English (US)",
volume = "591",
pages = "196--202",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - CGP12177-induced haemodynamic and vascular effects in normotensive and hypertensive rats

AU - Holopherne, Delphine

AU - Mallem, Mohamed Yassine

AU - Le Strat, Erwan

AU - Belin de Chantemele, Eric Jacques

AU - Gogny, Marc

AU - Henrion, Daniel

AU - Noireaud, Jacques

AU - Desfontis, Jean Claude

PY - 2008/9/4

Y1 - 2008/9/4

N2 - CGP12177 is a non-conventional partial agonist, known to have cardiostimulating and vasorelaxant properties related to its agonist action on the low affinity state of the β1-adrenoceptor (β1LA-adrenoceptor). In normotensive Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SHR), CGP12177-induced vasorelaxant effects were analysed in hindquarter vessels to assess modifications in hind limb vascular resistance, and in femoral artery rings. The global haemodynamic effects induced by CGP12177 were also investigated using telemetry in conscious animals. In hindquarters vasculature precontracted with 5-hydroxytryptamine, CGP12177 (0.16 to 475 μg) produced a similar dose-dependent decrease in hindquarters perfusion pressure in both strains. Vasorelaxation was not modified by nadolol, a β1 and β2-adrenoreceptor antagonist, nor by L748337, a β3-adrenoceptor antagonist, but was concentration dependently inhibited by bupranolol, a β1LA-adrenoceptor antagonist at high concentrations. In femoral artery rings from WKY rats and SHR, CGP12177 produced a concentration-dependent relaxation, which was unaffected by nitric oxide synthases inhibition but was significantly reduced in the presence of bupranolol. With double cardiac autonomic blockade (atropine plus atenolol) in conscious WKY rats and SHR, CGP12177 greatly increased heart rate with minor changes in mean arterial pressure in both strains. Conversely, in the absence of double cardiac autonomic blockade, the amplitude of CGP12177-induced heart rate increase was less pronounced and had an hypotensive effect. The reduction in tachycardia and the hypotension were significantly greater in SHR compared to WKY rats. In conclusion, in both strains, CGP12177 produced vasodilating effects in hindquarter vessels and femoral arteries that can be attributed to a β1LA-adrenoceptor stimulation. In conscious WKY rats and SHR, CGP12177-induced cardiostimulation and hypotension were not significantly different after baroreflex blockade, but were decreased and increased respectively, in the presence of baroreflex activity.

AB - CGP12177 is a non-conventional partial agonist, known to have cardiostimulating and vasorelaxant properties related to its agonist action on the low affinity state of the β1-adrenoceptor (β1LA-adrenoceptor). In normotensive Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SHR), CGP12177-induced vasorelaxant effects were analysed in hindquarter vessels to assess modifications in hind limb vascular resistance, and in femoral artery rings. The global haemodynamic effects induced by CGP12177 were also investigated using telemetry in conscious animals. In hindquarters vasculature precontracted with 5-hydroxytryptamine, CGP12177 (0.16 to 475 μg) produced a similar dose-dependent decrease in hindquarters perfusion pressure in both strains. Vasorelaxation was not modified by nadolol, a β1 and β2-adrenoreceptor antagonist, nor by L748337, a β3-adrenoceptor antagonist, but was concentration dependently inhibited by bupranolol, a β1LA-adrenoceptor antagonist at high concentrations. In femoral artery rings from WKY rats and SHR, CGP12177 produced a concentration-dependent relaxation, which was unaffected by nitric oxide synthases inhibition but was significantly reduced in the presence of bupranolol. With double cardiac autonomic blockade (atropine plus atenolol) in conscious WKY rats and SHR, CGP12177 greatly increased heart rate with minor changes in mean arterial pressure in both strains. Conversely, in the absence of double cardiac autonomic blockade, the amplitude of CGP12177-induced heart rate increase was less pronounced and had an hypotensive effect. The reduction in tachycardia and the hypotension were significantly greater in SHR compared to WKY rats. In conclusion, in both strains, CGP12177 produced vasodilating effects in hindquarter vessels and femoral arteries that can be attributed to a β1LA-adrenoceptor stimulation. In conscious WKY rats and SHR, CGP12177-induced cardiostimulation and hypotension were not significantly different after baroreflex blockade, but were decreased and increased respectively, in the presence of baroreflex activity.

KW - CGP12177

KW - Femoral artery

KW - Haemodynamic effects

KW - Hypertension

KW - Isolated perfused hindquarters

KW - Low affinity β-adrenoceptor

KW - Telemetry

UR - http://www.scopus.com/inward/record.url?scp=48949099307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48949099307&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2008.06.060

DO - 10.1016/j.ejphar.2008.06.060

M3 - Article

VL - 591

SP - 196

EP - 202

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -